Market Value332,470,540
Total Holdings28
File Date2026-02-17
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
PRLD / Prelude Therapeutics Incorporated
BCAX / Bicara Therapeutics Inc.
OBIO / Orchestra BioMed Holdings, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
THRD / Third Harmonic Bio, Inc.
KALV / KalVista Pharmaceuticals, Inc.
JSPR / Jasper Therapeutics, Inc.
TERN / Terns Pharmaceuticals, Inc.
RCUS / Arcus Biosciences, Inc.
ITOS / iTeos Therapeutics, Inc.
MIST / Milestone Pharmaceuticals Inc.
ARVN / Arvinas, Inc.
SMMT / Summit Therapeutics Inc.
TYRA / Tyra Biosciences, Inc.
APGE / Apogee Therapeutics, Inc.
IOVA / Iovance Biotherapeutics, Inc.
ZURA / Zura Bio Limited
NRIX / Nurix Therapeutics, Inc.
TNGX / Tango Therapeutics, Inc.
RVMD / Revolution Medicines, Inc.
SLDB / Solid Biosciences Inc.
KYMR / Kymera Therapeutics, Inc.
QURE / uniQure N.V.
BDTX / Black Diamond Therapeutics, Inc.
RLAY / Relay Therapeutics, Inc.
GERN / Geron Corporation
PSTX / Poseida Therapeutics, Inc.
MRSN / Mersana Therapeutics, Inc.
SRRK / Scholar Rock Holding Corporation
OLMA / Olema Pharmaceuticals, Inc.
SANA / Sana Biotechnology, Inc.
SWTX / SpringWorks Therapeutics, Inc.
CGEM / Cullinan Therapeutics, Inc.
KROS / Keros Therapeutics, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
SYRE / Spyre Therapeutics, Inc.
NUVL / Nuvalent, Inc.
MRUS / Merus N.V.
RNA / Atrium Therapeutics, Inc.
ANAB / AnaptysBio, Inc.
XENE / Xenon Pharmaceuticals Inc.
APLS / Apellis Pharmaceuticals, Inc.
CMRX / Chimerix, Inc.
ELVN / Enliven Therapeutics, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
PRTA / Prothena Corporation plc
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
AMLX / Amylyx Pharmaceuticals, Inc.
DNLI / Denali Therapeutics Inc.
TIL / Instil Bio, Inc.
BOLD / Boundless Bio, Inc.
CLYM / Climb Bio, Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
SRZNW / Surrozen, Inc. - Equity Warrant
BCAB / BioAtla, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
IMVT / Immunovant, Inc.
AXSM / Axsome Therapeutics, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
REPL / Replimune Group, Inc.
KOD / Kodiak Sciences Inc.